Details for Patent: RE41065
✉ Email this page to a colleague
Summary for Patent: RE41065
Title: | Alkynl and azido-substituted 4-anilinoquinazolines |
Abstract: | The invention relates to compounds of the formula ##STR00001## and to pharmaceutically acceptable salts thereof, wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, n and m are as defined herein. The compounds of formula I are useful in the treatment of hyperproliferative diseases, such as cancer. The invention further relates to processes of making the compounds of formula I and to methods of using such compounds in the treatment of hyperproliferative diseases. |
Inventor(s): | Schnur; Rodney Caughren (Noank, CT), Arnold; Lee Daniel (Mt. Sinai, NY) |
Assignee: | Pfizer, Inc. (New York, NY) OSI Pharmaceuticals, Inc. (Melville, NY) |
Application Number: | 12/038,530 |
Patent Claim Types: see list of patent claims | Compound; Use; Composition; Process; |
Drugs Protected by US Patent RE41065
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent RE41065
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 0817775 | ⤷ Sign Up | 300214 | Netherlands | ⤷ Sign Up |
European Patent Office | 0817775 | ⤷ Sign Up | 91209 | Luxembourg | ⤷ Sign Up |
European Patent Office | 0817775 | ⤷ Sign Up | SPC/GB06/008 | United Kingdom | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |